Serial 99402638
Live / Applied — Non-final action mailed (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 19 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99402638
- Mark type
- Design / logo
- Filed
- 19 Sept 2025
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
Owner
- Purdue Pharma L.P., Stamford, CT, US
Prosecution history
- 20 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Feb 2026 — NON-FINAL ACTION E-MAILED
- 20 Feb 2026 — NON-FINAL ACTION WRITTEN
- 11 Feb 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 10 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Sept 2025 — NEW APPLICATION ENTERED